Skip to content

The value of F-18-fluorodeoxyglucose Positron Emission Tomography for detection of Metastatic Infectious foci complicating gram-positive bacteraemia

The value of F-18-fluorodeoxyglucose Positron Emission Tomography for detection of Metastatic Infectious foci complicating gram-positive bacteraemia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN76425553
Enrollment
115
Registered
2007-05-02
Start date
2005-11-01
Completion date
Unknown
Last updated
2022-11-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metastatic infection/ gram-positive bacteraemia Infections and Infestations Metastatic infection/ gram-positive bacteraemia

Interventions

FDG-PET will be performed within 14 days after initiation of treatment. The attending physician will be informed of the results of FDG-PET immediately. Special attention will be paid to confirmation o

Sponsors

University Medical Centre St. Radboud (The Netherlands)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. All patients with blood cultures containing one of the following micro-organisms: a. Streptococcus aureus b. Streptococcus species (excluding S. pneumoniae) c. Enterococcus species 2. AND at least one of the following risk factors for metastatic infection: a. Community acquired infection b. Signs of infection for more than 48 hours before initiation of appropriate treatment c. Skin lesions or other symptoms or signs pointing to possible metastatic infection d. Fever lasting for more than 72 hours after initiation of appropriate treatment e. Positive blood cultures for more than 48 hours after initiation of appropriate treatment 3. Informed consent

Exclusion criteria

Exclusion criteria: 1. Age less than 18 years 2. Polymicrobial infection 3. Pregnancy 4. Critically ill patients initially admitted to the Intensive Care Unit (ICU) department for more than 14 days 5. Chemotherapeutically induced neutropenia

Design outcomes

Primary

MeasureTime frame
Relapse rate of infection

Secondary

MeasureTime frame
1. Attributable mortality 2. Mortality after relapse 3. Duration of first admission 4. Duration of antibiotic treatment 5. Number of diagnostic procedures performed to confirm metastatic foci, duration of admission due to relapse 6. Associated costs

Countries

Netherlands

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026